Earnings History Data for Innoviva, Inc. (INVA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Innoviva, Inc.

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-05-2023 AH 4:05 PM ET
(May 9)		 INVA Innoviva, Inc. 795.71 0.42 0.00 0.42 Innoviva GAAP EPS of $0.51, revenue of $76.37M
[5/9/2023 5:45 PM]		 12.22 0.66 
(5.75%)		 0.0 0.0 
(0.00%)		 10.64 - 16.67 734,433 430,000 0
28-02-2023 AH INVA Innoviva, Inc. 859.73 0.25 0.41 0.55 InnovivaEPS of -$0.98, revenue of $65.8M beats by $6.95M
[2/28/2023 4:59 PM]		 11.37 -0.71 
(-5.84%)		 0.0 0.0 
(0.00%)		 11.14 - 20.71 1,460,031 550,000 0
28-07-2021 AH 4:05 PM ET
(Jul 28)		 INVA Innoviva, Inc. 1,336 0.90 0.29 0.00 14.10 0.46 
(3.37%)		 13.85 0.21 
(1.54%)		 9.21 - 14.42 657,886 390,000 501
28-04-2021 AH 4:05 PM ET
(Apr 28)		 INVA Innoviva, Inc. 1,196 0.84 -0.01 0.00 Innoviva reports Q1 results
[4/28/2021 5:24 PM]		 11.68 0.09 
(0.78%)		 11.80 0.21 
(1.81%)		 9.21 - 15.62 359,227 470,000 12,523
03-02-2021 AH 4:30 PM ET
(Feb 3)		 INVA Innoviva, Inc. 1,250 0.48 0.40 0.42 Innoviva reports Q4 results
[2/3/2021 4:21 PM]		 12.51 0.06 
(0.48%)		 12.93 0.48 
(3.86%)		 7.58 - 15.62 457,822 449,146 107
29-07-2020 AH 4:05 PM ET
(Jul 29)		 INVA Innoviva, Inc. 1,410 0.69 0.32 0.34 Innoviva EPS beats by $0.37
[7/29/2020 4:50 PM]		 13.60 0.31 
(2.33%)		 13.65 0.36 
(2.71%)		 7.58 - 15.62 288,844 451,566 200